IWC
CORT icon

Integrated Wealth Concepts’s Corcept Therapeutics CORT Stock Holding History

Integrated Wealth Concepts’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558K Buy
+6,423
New +$388K ﹤0.01% 1590
2025
Q4 		– Sell
-2,979
Closed -$248K – 1700
2025
Q3 		$248K Buy
+2,979
New +$216K ﹤0.01% 1745

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integrated Wealth Concepts's CORT Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 6,423 shares worth $558K. The stake represents ﹤0.01% of the portfolio and ranks #1590 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in CORT as recently as Q3 2025.

Integrated Wealth Concepts first reported a position in CORT in Q3 2025 and has held it in 2 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Integrated Wealth Concepts held 6,423 shares of Corcept Therapeutics worth $558K as of Q2 2026.
  • Corcept Therapeutics was a new Integrated Wealth Concepts position in Q2 2026.
  • Corcept Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #1590 holding.
  • Integrated Wealth Concepts first reported a position in Corcept Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.